0001209191-20-026153.txt : 20200429 0001209191-20-026153.hdr.sgml : 20200429 20200429161441 ACCESSION NUMBER: 0001209191-20-026153 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200428 FILED AS OF DATE: 20200429 DATE AS OF CHANGE: 20200429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Yuchun CENTRAL INDEX KEY: 0001334365 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20830467 MAIL ADDRESS: STREET 1: 170 TRACER LA. CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-28 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001334365 Lee Yuchun C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2020-04-28 4 M 0 1125 57.27 A 3000 D Common Stock 2020-04-28 4 S 0 200 254.81 D 2800 D Common Stock 2020-04-28 4 S 0 240 255.79 D 2560 D Common Stock 2020-04-28 4 S 0 149 257.20 D 2411 D Common Stock 2020-04-28 4 S 0 120 258.53 D 2291 D Common Stock 2020-04-28 4 S 0 120 259.61 D 2171 D Common Stock 2020-04-28 4 S 0 180 260.53 D 1991 D Common Stock 2020-04-28 4 S 0 116 261.80 D 1875 D Stock Option (Right to Buy) 57.27 2020-04-28 4 M 0 1125 0.00 D 2022-09-13 Common Stock 1125 0 D Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $254.81 (range $254.32 to $255.26). Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $255.79 (range $255.40 to $256.14). Open market sales reported on this line occurred at a weighted average price of $257.20 (range $256.87 to $257.37). Open market sales reported on this line occurred at a weighted average price of $258.53 (range $258.13 to $258.92). Open market sales reported on this line occurred at a weighted average price of $259.61 (range $259.28 to $259.94). Open market sales reported on this line occurred at a weighted average price of $260.53 (range $260.32 to $260.94). Open market sales reported on this line occurred at a weighted average price of $261.80 (range $261.58 to $262.00). Fully vested. /s/ Omar White, Attorney-in-Fact 2020-04-29